The Top Biosimilars Interviews of 2017

2017 brought a number of notable guests to The Center for Biosimilars®. Here are the most-watched interviews of the year.

2017 brought a number of notable guests to The Center for Biosimilars®. Below are the most-watched interviews of the year:

Number 5: Marcus H. Snow, MD, Assistant Professor Rheumatology, University of Nebraska, discusses the recent launch of a new biosimilar infliximab, Renflexis, in the United States.

Number 4: Brandon Shank, PharmD, MPH, BCOP, Clinical Pharmacy Specialist, discusses the importance of pharmacist education on biosimilar treatments.

Number 3: Joseph Fuhr, PhD, explains why biosimilars could bring on brand-to-brand competition.

Number 2: Angus Worthing, MD, FACR, FACP, discusses the benefits of biosimilar medicines.

Number 1: Ha Kung Wong, JD, Partner at Fitzpatrick, Cella, Harper and Scinto, discusses incentives for biosimilar applicants to engage in the BPCIA "patent dance" after the Supreme Court's ruling in Sandoz v Amgen.

Related Videos
Michael Kleinrock
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Michael Kleinrock
Ian Henshaw
Ian Henshaw
Ryan Haumschild, PharmD
John Gabrielson
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumdschild, PharmD
Ryan Haumschild, PharmD
Related Content
© 2023 MJH Life Sciences

All rights reserved.